drugset / Trial / NCT00806221

An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis

NCT00806221 ↗

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether early use of a bland emollient in newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the development of atopic dermatitis.

Timeline

Start
2006-11
Primary completion
2008-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetaphil cream Unknown — Topical

Indications